AIN
SyCap Knee Implant

SyCap Knee Implant

location_on Limburg ,  Netherlands

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Over 1.4M cartilage repair procedures are globally done a year but there is a treatment gap for the middle aged patients. Our implant will solve this gap between regenerative therapy and TKR with an implant co-invented by an orthopedic surgeon.

Highlights

  • SyCap is a groundbreaking solution for middle-aged patients
  • Designed to postpone the need for total knee replacement
  • €1.4B projected market by 2030, with over 320,000 treatable cases annually
  • Potential product line expansion based on IP to other joints
  • Improve quality of life for patients with a cartilage defect

Overview

Target CHF 1,400,000
Minimum CHF 45,000
Investment Raised CHF 650,000
Previous Rounds CHF 475,000
Stage Other
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects